Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Targeting NLRP3 Inflammasome Activation in Severe Asthma.

Theofani E, Semitekolou M, Morianos I, Samitas K, Xanthou G.

J Clin Med. 2019 Oct 4;8(10). pii: E1615. doi: 10.3390/jcm8101615. Review.

2.

High Proliferation Rate and a Compromised Spindle Assembly Checkpoint Confers Sensitivity to the MPS1 Inhibitor BOS172722 in Triple-Negative Breast Cancers.

Anderhub SJ, Mak GW, Gurden MD, Faisal A, Drosopoulos K, Walsh K, Woodward HL, Innocenti P, Westwood IM, Naud S, Hayes A, Theofani E, Filosto S, Saville H, Burke R, van Montfort RLM, Raynaud FI, Blagg J, Hoelder S, Eccles SA, Linardopoulos S.

Mol Cancer Ther. 2019 Oct;18(10):1696-1707. doi: 10.1158/1535-7163.MCT-18-1203.

PMID:
31575759
3.

Ectopic Lck expression in CLL demarcates intratumoral subpopulations with aberrant B-cell receptor signaling.

Theofani E, Alexis S, Costeas P, Andriopoulos C, Feleskoura G, Zikos P, Aktypi A, Spyridonidis A, Nika K.

Blood Adv. 2018 Apr 24;2(8):877-882. doi: 10.1182/bloodadvances.2017015321. No abstract available.

4.

Simple in vitro generation of human leukocyte antigen-G-expressing T-regulatory cells through pharmacological hypomethylation for adoptive cellular immunotherapy against graft-versus-host disease.

Stamou P, Marioli D, Patmanidi AL, Sgourou A, Vittoraki A, Theofani E, Pierides C, Taraviras S, Costeas PA, Spyridonidis A.

Cytotherapy. 2017 Apr;19(4):521-530. doi: 10.1016/j.jcyt.2017.01.004. Epub 2017 Feb 2.

PMID:
28162915

Supplemental Content

Loading ...
Support Center